Benjamin F. Edwards & Company, Inc. Coll Plant Biotechnologies LTD Call Options Transaction History
Benjamin F. Edwards & Company, Inc.
- $5.69 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding CLGN
# of Institutions
21Shares Held
2.69MCall Options Held
0Put Options Held
0-
Villere St Denis J & CO LLC589KShares$1.27 Million0.16% of portfolio
-
Pinnacle Associates LTD507KShares$1.09 Million0.01% of portfolio
-
Investment Management Of Virginia LLC464KShares$997,3820.63% of portfolio
-
Roumell Asset Management, LLC Chevy Chase, MD276KShares$594,3242.69% of portfolio
-
Heights Capital Management, Inc San Francisco, CA275KShares$591,4260.1% of portfolio
About CollPlant Biotechnologies Ltd
- Ticker CLGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,086,500
- Market Cap $23.8M
- Description
- CollPlant Biotechnologies Ltd., a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe. Its products are based on recombinant type I human collagen that is produced with its proprietary plant based genetic engineering tech...